Colitis ulcerosa: vizsgálatok itt: India
10 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleLY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Where
- Ahmedabad, Chennai, Coimbatore, Hubli, Hyderabad, New Delhi, Pune, Rajkot
- Életkor
- 18 év to 80 év
- People
- 252 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07186101 - 2. fázisTaking peopleLY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Where
- Allahabād, Belagavi, Belgavi, Hyderabad, Jaipur, Kochi, Lucknow, Mumbai, Nagpur, New Delhi, Noida, Pune
- Életkor
- 18 év to 80 év
- People
- 1431 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07415044 - 3. fázisTaking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Hubli, Hyderabad, Jaipur, Kochi, Mumbai (ex Bombay), Secunderabad, Surat
- Életkor
- 18 év and over
- People
- 644 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Where
- Hyderabad, Jaipur, Kolkata, Nagpur, Rajkot
- Életkor
- 18 év and over
- People
- 224 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT06979336 · EU 2025-520690-39-00 - 2. fázisTaking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Hyderabad, Jaipur, Kochi, New Delhi, Sūrat
- Életkor
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00 - No phaseTaking peopleProspective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD
- Where
- Hyderabad
- Életkor
- 18 év to 80 év
- People
- 200
- Run by
- Asian Institute of Gastroenterology, India
See details and how to joinNCT07431983 - 2. fázisNot yet taking people in IndiaCombination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial
- Where
- Hyderabad
- Életkor
- 18 év to 65 év
- People
- 60
- Run by
- Asian Institute of Gastroenterology, India
See details and how to joinNCT07297069 - No phaseTaking peopleComparing Diagnostic Accuracy of High-end Intestinal Ultrasound Versus Mid-end Ultrasound With Tandem Ileo-colonoscopy in Inflammatory Bowel Disease : a Paired, Validating Confirmatory Study
- Where
- Hyderabad
- Életkor
- 18 év to 75 év
- People
- 500
- Run by
- Asian Institute of Gastroenterology, India
See details and how to joinNCT06938295 - No phaseTaking peopleA Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis
- Where
- Chandigarh, Kochi, Ludhiana, Mumbai, New Delhi, Varanasi
- Életkor
- 18 év to 75 év
- People
- 220
- Run by
- All India Institute of Medical Sciences
See details and how to joinNCT06895252 - No phaseTaking peopleA Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies
- Where
- Chandigarh, Kochi, Ludhiana, Mumbai, New Delhi, Varanasi
- Életkor
- 18 év to 75 év
- People
- 220
- Run by
- All India Institute of Medical Sciences
See details and how to joinNCT06906445